Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors

✍ Scribed by E. Claire Dees; Jeffrey R. Infante; Roger B. Cohen; Bert H. O’Neil; Suzanne Jones; Margaret von Mehren; Hadi Danaee; Yih Lee; Jeffrey Ecsedy; Mark Manfredi; Katherine Galvin; Bradley Stringer; Hua Liu; Omar Eton; Howard Fingert; Howard Burris

• Publisher: Springer
• Year: 2010
• Tongue: English
• Weight: 328 KB
• Volume: 67
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-010-1377-y